ACTR6 |
Q9GZN1
|
actin related protein 6
|
Cellular structure
|
5.5E-09 |
0.931 |
0.038 |
DFNB20 |
|
deafness, autosomal recessive 20
|
|
|
1.000 |
0.115 |
RBM15 |
Q96T37
|
RNA binding motif protein 15
|
|
0.99 |
0.736 |
0.154 |
LRRC17 |
Q8N6Y2
|
leucine rich repeat containing 17
|
Receptor
|
1.1E-07 |
0.805 |
0.154 |
DDX17 |
Q92841
|
DEAD-box helicase 17
|
|
1.00 |
0.769 |
0.192 |
MLSM7 |
|
Myelodysplasia and leukemia syndrome with monosomy 7
|
|
|
0.743 |
0.192 |
PXMP2 |
Q9NR77
|
peroxisomal membrane protein 2
|
Receptor
|
9.2E-03 |
0.743 |
0.192 |
RASA4 |
O43374
|
RAS p21 protein activator 4
|
Enzyme modulator
|
0.12 |
0.821 |
0.192 |
EIF1AX |
P47813
|
eukaryotic translation initiation factor 1A X-linked
|
Nucleic acid binding
|
0.91 |
0.716 |
0.231 |
AVEN |
Q9NQS1
|
apoptosis and caspase activation inhibitor
|
|
2.7E-09 |
0.760 |
0.231 |
HLA-J |
|
major histocompatibility complex, class I, J (pseudogene)
|
|
|
0.861 |
0.269 |
SLC25A15 |
Q9Y619
|
solute carrier family 25 member 15
|
Transporter
|
3.7E-07 |
0.711 |
0.346 |
CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
MIR595 |
|
microRNA 595
|
|
|
0.722 |
0.346 |
EVPL |
Q92817
|
envoplakin
|
Cellular structure
|
5.7E-25 |
0.599 |
0.423 |
RING1 |
Q06587
|
ring finger protein 1
|
|
0.65 |
0.653 |
0.423 |
CDC42EP3 |
Q9UKI2
|
CDC42 effector protein 3
|
|
0.19 |
0.722 |
0.423 |
OCM |
P0CE72
|
oncomodulin
|
|
1.1E-08 |
0.751 |
0.423 |
GLIS2 |
Q9BZE0
|
GLIS family zinc finger 2
|
Transcription factor
|
0.86 |
0.608 |
0.462 |
DERL3 |
Q96Q80
|
derlin 3
|
Receptor
|
2.2E-04 |
0.691 |
0.462 |
FRA7G |
|
fragile site, aphidicolin type, common, fra(7)(q31.2)
|
|
|
0.695 |
0.462 |
RPS14 |
P62263
|
ribosomal protein S14
|
Nucleic acid binding
|
0.90 |
0.631 |
0.500 |
BIRC7 |
Q96CA5
|
baculoviral IAP repeat containing 7
|
Enzyme modulator
|
1.1E-07 |
0.621 |
0.500 |
CREBRF |
Q8IUR6
|
CREB3 regulatory factor
|
|
1.00 |
0.636 |
0.500 |
SAMD9L |
Q8IVG5
|
sterile alpha motif domain containing 9 like
|
|
5.6E-15 |
0.700 |
0.500 |